Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Creemers JH"'
Autor:
Boudewijns S; Departments of *Medical Oncology †Tumor Immunology ‡Radiology and Nuclear Medicine, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen §Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands., Westdorp H, Koornstra RH, Aarntzen EH, Schreibelt G, Creemers JH, Punt CJ, Figdor CG, de Vries IJ, Gerritsen WR, Bol KF
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2016 Jul-Aug; Vol. 39 (6), pp. 241-8.
Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination.
Autor:
Bol KF; Department of Tumor Immunology; Radboud Institute for Molecular Life Sciences; Radboud University Medical Center; Nijmegen, The Netherlands; Department of Medical Oncology; Radboud University Medical Center; Nijmegen, The Netherlands., Aarntzen EH; Department of Tumor Immunology; Radboud Institute for Molecular Life Sciences; Radboud University Medical Center; Nijmegen, The Netherlands; Department of Medical Oncology; Radboud University Medical Center; Nijmegen, The Netherlands; Department of Radiology and Nuclear Medicine; Radboud University Medical Center; Nijmegen, The Netherlands., Hout FE; Department of Tumor Immunology; Radboud Institute for Molecular Life Sciences; Radboud University Medical Center; Nijmegen, The Netherlands; Department of Surgical Oncology; Radboud University Medical Center; Nijmegen, The Netherlands., Schreibelt G; Department of Tumor Immunology; Radboud Institute for Molecular Life Sciences; Radboud University Medical Center ; Nijmegen, The Netherlands., Creemers JH; Department of Tumor Immunology; Radboud Institute for Molecular Life Sciences; Radboud University Medical Center ; Nijmegen, The Netherlands., Lesterhuis WJ; Department of Tumor Immunology; Radboud Institute for Molecular Life Sciences; Radboud University Medical Center; Nijmegen, The Netherlands; Department of Medicine and Pharmacology; University of Western Australia; Crawley, Australia., Gerritsen WR; Department of Medical Oncology; Radboud University Medical Center ; Nijmegen, The Netherlands., Grunhagen DJ; Department Surgical Oncology; Erasmus MC Cancer Institute ; Rotterdam, The Netherlands., Verhoef C; Department Surgical Oncology; Erasmus MC Cancer Institute ; Rotterdam, The Netherlands., Punt CJ; Department of Medical Oncology; Academic Medical Center ; Amsterdam, The Netherlands., Bonenkamp JJ; Department of Surgical Oncology; Radboud University Medical Center ; Nijmegen, The Netherlands., de Wilt JH; Department of Surgical Oncology; Radboud University Medical Center ; Nijmegen, The Netherlands., Figdor CG; Department of Tumor Immunology; Radboud Institute for Molecular Life Sciences; Radboud University Medical Center ; Nijmegen, The Netherlands., de Vries IJ; Department of Tumor Immunology; Radboud Institute for Molecular Life Sciences; Radboud University Medical Center; Nijmegen, The Netherlands; Department of Medical Oncology; Radboud University Medical Center; Nijmegen, The Netherlands.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2015 Jun 05; Vol. 5 (1), pp. e1057673. Date of Electronic Publication: 2015 Jun 05 (Print Publication: 2016).